Literature DB >> 21068362

Apical and basolateral pools of proteinase-activated receptor-2 direct distinct signaling events in the intestinal epithelium.

Chang Lau1, Christian Lytle, Daniel S Straus, Kathryn A DeFea.   

Abstract

Studies suggest that there are two distinct pools of proteinase-activated receptor-2 (PAR₂) present in intestinal epithelial cells: an apical pool accessible from the lumen, and a basolateral pool accessible from the interstitial space and blood. Although introduction of PAR₂ agonists such as 2-furoyl-LIGRL-O-NH₂ (2fAP) to the intestinal lumen can activate PAR₂, the presence of accessible apical PAR₂ has not been definitively shown. Furthermore, some studies have suggested that basolateral PAR₂ responses in the intestinal epithelium are mediated indirectly by neuropeptides released from enteric nerve fibers, rather than by intestinal PAR₂ itself. Here we identified accessible pools of both apical and basolateral PAR₂ in cultured Caco2-BBe monolayers and in mouse ileum. Activation of basolateral PAR₂ transiently increased short-circuit current by activating electrogenic Cl⁻ secretion, promoted dephosphorylation of the actin filament-severing protein, cofilin, and activated the transcription factor, AP-1, whereas apical PAR₂ did not. In contrast, both pools of PAR₂ activated extracellular signal-regulated kinase 1/2 (ERK1/2) via temporally and mechanistically distinct pathways. Apical PAR₂ promoted a rapid, biphasic PLCβ/Ca²(+)/PKC-dependent ERK1/2 activation, resulting in nuclear localization, whereas basolateral PAR₂ promoted delayed ERK1/2 activation which was predominantly restricted to the cytosol, involving both PLCβ/Ca²(+) and β-arrestin-dependent pathways. These results suggest that the outcome of PAR₂ activation is dependent on the specific receptor pool that is activated, allowing for fine-tuning of the physiological responses to different agonists.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21068362      PMCID: PMC3023197          DOI: 10.1152/ajpcell.00162.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  58 in total

1.  The proteinase-activated receptor 2 is involved in nociception.

Authors:  W A Hoogerwerf; L Zou; M Shenoy; D Sun; M A Micci; H Lee-Hellmich; S Y Xiao; J H Winston; P J Pasricha
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

Review 2.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

3.  Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates.

Authors:  T Takeuchi; J L Harris; W Huang; K W Yan; S R Coughlin; C S Craik
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

4.  Activation of ion secretion via proteinase-activated receptor-2 in human colon.

Authors:  Marcus Mall; Tanja Gonska; Jörg Thomas; Stephanie Hirtz; Rainer Schreiber; Karl Kunzelmann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-02       Impact factor: 4.052

5.  Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis.

Authors:  S Fiorucci; A Mencarelli; B Palazzetti; E Distrutti; N Vergnolle; M D Hollenberg; J L Wallace; A Morelli; G Cirino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.

Authors:  E Camerer; W Huang; S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

7.  Functional activity of hepatocyte nuclear factor-1 is specifically decreased in amino acid-limited hepatoma cells.

Authors:  N W Marten; C H Hsiang; L Yu; N S Stollenwerk; D S Straus
Journal:  Biochim Biophys Acta       Date:  1999-10-28

Review 8.  AP-1 in cell proliferation and survival.

Authors:  E Shaulian; M Karin
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

9.  beta-Arrestins scaffold cofilin with chronophin to direct localized actin filament severing and membrane protrusions downstream of protease-activated receptor-2.

Authors:  Maria Zoudilova; Jungah Min; Heddie L Richards; David Carter; Timothy Huang; Kathryn A DeFea
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

10.  Basolateral PAR-2 receptors mediate KCl secretion and inhibition of Na+ absorption in the mouse distal colon.

Authors:  John E Cuffe; Marko Bertog; Sara Velázquez-Rocha; Olivier Dery; Nigel Bunnett; Christoph Korbmacher
Journal:  J Physiol       Date:  2002-02-15       Impact factor: 5.182

View more
  18 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

Review 2.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

Review 3.  New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2.

Authors:  Terry Kenakin
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

4.  Lanthanide labeling of a potent protease activated receptor-2 agonist for time-resolved fluorescence analysis.

Authors:  Justin Hoffman; Andrea N Flynn; Dipti V Tillu; Zhenyu Zhang; Renata Patek; Theodore J Price; Josef Vagner; Scott Boitano
Journal:  Bioconjug Chem       Date:  2012-10-08       Impact factor: 4.774

Review 5.  Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.

Authors:  Louis M Luttrell
Journal:  Mol Endocrinol       Date:  2014-01-16

6.  A highly potent agonist to protease-activated receptor-2 reveals apical activation of the airway epithelium resulting in Ca2+-regulated ion conductance.

Authors:  Cara L Sherwood; Michael O Daines; Theodore J Price; Josef Vagner; Scott Boitano
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-15       Impact factor: 4.249

7.  Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.

Authors:  Bonan Lin; Xiaomeng Zhou; Shuye Lin; Xiaoyue Wang; Meiying Zhang; Baoping Cao; Yan Dong; Shuai Yang; Ji Ming Wang; Mingzhou Guo; Jiaqiang Huang
Journal:  J Mol Med (Berl)       Date:  2017-08-26       Impact factor: 4.599

Review 8.  Measurement of novel intestinal secretory and barrier pathways and effects of proteases.

Authors:  Adam L Edwinson; Madhusudan Grover
Journal:  Neurogastroenterol Motil       Date:  2019-04       Impact factor: 3.598

9.  Reelin is involved in the crypt-villus unit homeostasis.

Authors:  Pablo García-Miranda; María D Vázquez-Carretero; Pilar Sesma; María J Peral; Anunciación A Ilundain
Journal:  Tissue Eng Part A       Date:  2012-09-24       Impact factor: 3.845

10.  Extracellular nucleotides inhibit oxalate transport by human intestinal Caco-2-BBe cells through PKC-δ activation.

Authors:  Ruhul Amin; Sapna Sharma; Sireesha Ratakonda; Hatim A Hassan
Journal:  Am J Physiol Cell Physiol       Date:  2013-04-17       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.